Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Bilibili Inc has a consensus price target of $29.35 based on the ratings of 17 analysts. The high is $120 issued by Baird on August 18, 2023. The low is $13 issued by Bernstein on August 23, 2024. The 3 most-recent analyst ratings were released by Citigroup, Benchmark, and Bernstein on November 14, 2025, November 14, 2025, and October 23, 2025, respectively. With an average price target of $29.33 between Citigroup, Benchmark, and Bernstein, there's an implied 11.62% upside for Bilibili Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/14/2025 | 2.74% | Citigroup | $25 → $27 | Maintains | Neutral | |||
11/14/2025 | 10.35% | Benchmark | $28 → $29 | Maintains | Buy | |||
10/23/2025 | 21.77% | Bernstein | $28 → $32 | Maintains | Outperform | |||
10/14/2025 | 37.1% | Macquarie | → $36.03 | Initiates | → Outperform | |||
08/22/2025 | 6.54% | Barclays | $25 → $28 | Maintains | Overweight | |||
08/22/2025 | 6.54% | Benchmark | $30 → $28 | Maintains | Buy | |||
07/28/2025 | -8.68% | JP Morgan | $21 → $24 | Downgrade | Overweight → Neutral | |||
07/17/2025 | 2.74% | B of A Securities | $25 → $27 | Maintains | Buy | |||
07/08/2025 | 6.54% | Bernstein | → $28 | Initiates | → Outperform | |||
05/21/2025 | -14.38% | HSBC | — | $21.5 → $22.5 | Upgrade | Hold → Buy | ||
02/21/2025 | 14.16% | Benchmark | $24 → $30 | Maintains | Buy | |||
02/21/2025 | -4.87% | Barclays | $24 → $25 | Maintains | Overweight | |||
11/18/2024 | -8.68% | Barclays | $19 → $24 | Maintains | Overweight | |||
11/15/2024 | -8.68% | Benchmark | $16 → $24 | Maintains | Buy | |||
11/12/2024 | -20.09% | Mizuho | $17 → $21 | Maintains | Outperform | |||
10/25/2024 | -14.38% | B of A Securities | $19 → $22.5 | Maintains | Buy | |||
09/03/2024 | -27.7% | B of A Securities | $18 → $19 | Maintains | Buy | |||
08/23/2024 | -50.53% | Bernstein | $12 → $13 | Maintains | Market Perform | |||
08/23/2024 | -27.7% | Barclays | $14 → $19 | Upgrade | Equal-Weight → Overweight | |||
08/22/2024 | -31.51% | Nomura | → $18 | Upgrade | Neutral → Buy | |||
06/18/2024 | -20.09% | JP Morgan | → $21 | Upgrade | Neutral → Overweight | |||
05/31/2024 | -31.51% | UBS | $11.9 → $18 | Upgrade | Neutral → Buy | |||
05/24/2024 | -39.12% | Benchmark | $15 → $16 | Maintains | Buy | |||
05/24/2024 | -46.73% | Barclays | $10 → $14 | Upgrade | Underweight → Equal-Weight | |||
05/10/2024 | -36.07% | CLSA | $12.2 → $16.8 | Upgrade | Outperform → Buy | |||
05/10/2024 | -35.31% | Mizuho | $15 → $17 | Maintains | Buy | |||
03/11/2024 | -52.44% | Citigroup | $18 → $12.5 | Downgrade | Buy → Neutral | |||
03/11/2024 | -58.14% | JP Morgan | $10 → $11 | Upgrade | Underweight → Neutral | |||
03/08/2024 | -42.92% | Benchmark | $21 → $15 | Maintains | Buy | |||
03/08/2024 | -42.92% | Mizuho | $16 → $15 | Maintains | Buy | |||
01/17/2024 | -39.12% | Mizuho | $18 → $16 | Maintains | Buy | |||
12/04/2023 | -49.77% | UBS | $22 → $13.2 | Downgrade | Buy → Neutral | |||
11/30/2023 | -20.09% | Benchmark | $35 → $21 | Maintains | Buy | |||
11/30/2023 | -40.64% | Goldman Sachs | $17.4 → $15.6 | Maintains | Neutral | |||
11/30/2023 | -61.95% | Barclays | $15 → $10 | Downgrade | Equal-Weight → Underweight | |||
10/12/2023 | -33.79% | Goldman Sachs | $19.6 → $17.4 | Maintains | Neutral | |||
08/21/2023 | -42.92% | Barclays | $16 → $15 | Maintains | Equal-Weight | |||
08/18/2023 | -16.29% | UBS | $23 → $22 | Maintains | Buy | |||
08/18/2023 | 33.18% | Benchmark | → $35 | Reiterates | Buy → Buy | |||
08/18/2023 | 356.62% | Baird | $140 → $120 | Maintains | Neutral | |||
07/27/2023 | -50.53% | JP Morgan | → $13 | Downgrade | Overweight → Equal-Weight | |||
07/25/2023 | -39.12% | HSBC | $17 → $16 | Maintains | Hold | |||
06/08/2023 | -12.48% | UBS | $35 → $23 | Maintains | Buy | |||
06/05/2023 | 33.18% | Benchmark | → $35 | Reiterates | Buy → Buy | |||
06/02/2023 | 33.18% | Benchmark | → $35 | Reiterates | Buy → Buy | |||
06/02/2023 | -4.87% | B of A Securities | $28 → $25 | Maintains | Buy | |||
06/02/2023 | -8.68% | Citigroup | $28 → $24 | Maintains | Buy | |||
06/02/2023 | -35.31% | HSBC | $22 → $17 | Maintains | Hold | |||
03/03/2023 | 33.18% | Benchmark | → $35 | Reiterates | → Buy | |||
03/03/2023 | 6.54% | Citigroup | → $28 | Upgrade | Neutral → Buy | |||
01/09/2023 | -3.73% | Goldman Sachs | $22.2 → $25.3 | Maintains | Neutral | |||
11/30/2022 | -15.53% | Goldman Sachs | $25.6 → $22.2 | Maintains | Neutral | |||
11/30/2022 | -39.12% | Barclays | $13 → $16 | Maintains | Equal-Weight |
The latest price target for Bilibili (NASDAQ:BILI) was reported by Citigroup on November 14, 2025. The analyst firm set a price target for $27.00 expecting BILI to rise to within 12 months (a possible 2.74% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Bilibili (NASDAQ:BILI) was provided by Citigroup, and Bilibili maintained their neutral rating.
The last upgrade for Bilibili Inc happened on May 21, 2025 when HSBC raised their price target to $22.5. HSBC previously had a hold for Bilibili Inc.
The last downgrade for Bilibili Inc happened on July 28, 2025 when JP Morgan changed their price target from $21 to $24 for Bilibili Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bilibili, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bilibili was filed on November 14, 2025 so you should expect the next rating to be made available sometime around November 14, 2026.
While ratings are subjective and will change, the latest Bilibili (BILI) rating was a maintained with a price target of $25.00 to $27.00. The current price Bilibili (BILI) is trading at is $26.28, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.